KC
Krishna Chaitanya Lakkimsetti
About Krishna Chaitanya Lakkimsetti
Data last updated:
Krishna Chaitanya Lakkimsetti has 15 years in corporate governance. Holds Director role. Currently with 1 company, including Sri Prabha Bio-Technologies Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Sri Prabha Bio-Technologies Private Limited at ₹2.59 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jun 2011 | 2011 | ₹2.59 Cr (FY 2023) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Krishna Chaitanya Lakkimsetti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishna Chaitanya Lakkimsetti
Krishna Chaitanya Lakkimsetti has 15 years in corporate governance. Holds Director role. Currently with 1 company, including Sri Prabha Bio-Technologies Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Sri Prabha Bio-Technologies Private Limited at ₹2.59 Cr (FY 2023).
Krishna Chaitanya Lakkimsetti is associated with 1 company as Director, including Sri Prabha Bio-Technologies Private Limited (₹2.59 Cr).
Krishna Chaitanya Lakkimsetti has expertise in Technology.
Krishna Chaitanya Lakkimsetti has 15 years in corporate governance.
By reported revenue, the largest current company of Krishna Chaitanya Lakkimsetti is Sri Prabha Bio-Technologies Private Limited, with revenue of ₹2.59 Cr (FY 2023).
Krishna Chaitanya Lakkimsetti currently holds positions at 1 company: Sri Prabha Bio-Technologies Private Limited (₹2.59 Cr).